Table 3.
Complications and outcome.
| PP Group (n = 1343) number (%) | MC Group (n = 400) number (%) | p Value | |
|---|---|---|---|
| Complications at 24 h | |||
| Major Bleeding | 1 (0.074%) | 2 (0.5%) | 0.07 |
| Death related to bleeding | Nil | 01 (0.25%) | 0.06 |
| Minor bleeding | 16 (1.19%) | 12 (3%) | 0.01 |
| Hematoma> 5 cm | 18 (1.34%) | 16 (4%) | 0.0007 |
|
Complications at 30 days | |||
| Minor bleeding | 04 (0.298%) | 10 (2.5%) | <0.0001 |
| Hematoma | 12 (0.89%) | 14 (3.5%) | 0.0002 |
| Pseudoaneurysm | 0 | 02 (0.5%) | 0.0095 |
| Access site infection | 02 (0.15%) | 02 (0.5%) | 0.20 |
| Pain and Induration at access site | 16 (1.19%) | 4 (1%) | 0.75 |